The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Predicine; Roche/Genentech (I)
Leadership - Predicine
Stock and Other Ownership Interests - Predicine; Roche/Genentech (I)
Patents, Royalties, Other Intellectual Property - Predicine
Prognostic and predictive utility of DNA damage response (DDR) aberrations detected in cell-free DNA (cfDNA) in metastatic castration-resistant prostate cancer (mCRPC).
 
Heidi Fettke
No Relationships to Disclose
 
Christine Hauser
No Relationships to Disclose
 
Edmond Michael Kwan
Honoraria - Astellas Pharma; Ipsen; Janssen; Research Review
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Pfizer; Roche
 
Chao Dai
No Relationships to Disclose
 
Tiantian Zheng
No Relationships to Disclose
 
Amy Wang
Employment - Predicine
 
Winston Tan
Honoraria - Medscape; Onclive
 
Pan Du
Employment - Predicine
Leadership - Predicine
Stock and Other Ownership Interests - Predicine
Patents, Royalties, Other Intellectual Property - Predicine
 
Nicole Ng
No Relationships to Disclose
 
Patricia Bukczynska
No Relationships to Disclose
 
Siavash Foroughi
Stock and Other Ownership Interests - CSL Limited; Mesoblast; Oncosil
 
Lisa-Jane K. Graham
Patents, Royalties, Other Intellectual Property - I am listed in a 'Rewards to Inventors' Scheme with the Institute of Cancer Research London Enterprise Unit as part of a research project I was involved in working at the Institute of Cancer Research London (in collaboration with Astex Therapeutics (now A
 
Lisa Horvath
Employment - Connected Medical Solutions (I)
Leadership - Connected Medical Solutions (I)
Stock and Other Ownership Interests - Connected Medical Solutions (I); Imagion Biosystems
Consulting or Advisory Role - Imagion Biosystems
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag; Pfizer
 
Kate Lynette Mahon
Research Funding - Mundipharma
 
Shidong Jia
No Relationships to Disclose
 
Manish Kohli
Honoraria - Advanced Accelerator Applications
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Genapsys
Travel, Accommodations, Expenses - Celgene
 
Arun Azad
Honoraria - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); MedImmune (Inst); Merck Serono; Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Janssen; Merck Serono; Pfizer; Sanofi; Tolmar